Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
LAMP1 as a Target for PET Imaging in Adenocarcinoma Xenograft Models
by
Haj-Mirzaian, Arvin
, Heidari, Pedram
, Marcos Vidal, Asier
, Mahmood, Umar
, Ataeinia, Bahar
, Ben-Naim, Lital
, Esfahani, Shadi A.
in
Adenocarcinoma
/ Biomarkers
/ Breast cancer
/ Cell adhesion & migration
/ Colon cancer
/ Development and progression
/ Diagnosis
/ Fibroblasts
/ Flow cytometry
/ Gene expression
/ Health aspects
/ Immuno-PET
/ LAMP1
/ Lymphatic system
/ Membrane proteins
/ Metastasis
/ Pancreas
/ PET imaging
/ Physiological aspects
/ Physiology
/ Prostate
/ Uterus
2025
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
LAMP1 as a Target for PET Imaging in Adenocarcinoma Xenograft Models
by
Haj-Mirzaian, Arvin
, Heidari, Pedram
, Marcos Vidal, Asier
, Mahmood, Umar
, Ataeinia, Bahar
, Ben-Naim, Lital
, Esfahani, Shadi A.
in
Adenocarcinoma
/ Biomarkers
/ Breast cancer
/ Cell adhesion & migration
/ Colon cancer
/ Development and progression
/ Diagnosis
/ Fibroblasts
/ Flow cytometry
/ Gene expression
/ Health aspects
/ Immuno-PET
/ LAMP1
/ Lymphatic system
/ Membrane proteins
/ Metastasis
/ Pancreas
/ PET imaging
/ Physiological aspects
/ Physiology
/ Prostate
/ Uterus
2025
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
LAMP1 as a Target for PET Imaging in Adenocarcinoma Xenograft Models
by
Haj-Mirzaian, Arvin
, Heidari, Pedram
, Marcos Vidal, Asier
, Mahmood, Umar
, Ataeinia, Bahar
, Ben-Naim, Lital
, Esfahani, Shadi A.
in
Adenocarcinoma
/ Biomarkers
/ Breast cancer
/ Cell adhesion & migration
/ Colon cancer
/ Development and progression
/ Diagnosis
/ Fibroblasts
/ Flow cytometry
/ Gene expression
/ Health aspects
/ Immuno-PET
/ LAMP1
/ Lymphatic system
/ Membrane proteins
/ Metastasis
/ Pancreas
/ PET imaging
/ Physiological aspects
/ Physiology
/ Prostate
/ Uterus
2025
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
LAMP1 as a Target for PET Imaging in Adenocarcinoma Xenograft Models
Journal Article
LAMP1 as a Target for PET Imaging in Adenocarcinoma Xenograft Models
2025
Request Book From Autostore
and Choose the Collection Method
Overview
Background: Lysosomal-associated membrane protein 1 (LAMP1), typically localized to the lysosomal membrane, is increasingly implicated as a marker of cancer aggressiveness and metastasis when expressed on the cell surface. This study aimed to develop a LAMP1-targeted antibody-based PET tracer and assess its efficacy in mouse models of human breast and colon adenocarcinoma. Methods: To determine the source of LAMP1 expression, we utilized human single-cell RNA sequencing and spatial transcriptomics, complemented by in-house flow cytometry on xenografted mouse models. Tissue microarrays of multiple epithelial cancers and normal tissue were stained for LAMP-1, and staining was quantified. An anti-LAMP1 monoclonal antibody was conjugated with desferrioxamine (DFO) and labeled with zirconium-89 (89Zr). Human triple-negative breast cancer (MDA-MB-231) and colon cancer (Caco-2) cell lines were implanted in nude mice. PET/CT imaging was conducted at 24, 72, and 168 h post-intravenous injection of 89Zr-DFO-anti-LAMP1 and 89Zr-DFO-IgG (negative control), followed by organ-specific biodistribution analyses at the final imaging time point. Results: Integrated single-cell and spatial RNA sequencing demonstrated that LAMP1 expression was localized to myeloid-derived suppressor cells (MDSCs) and cancer-associated fibroblasts (CAFs) in addition to the cancer cells. Tissue microarray showed significantly higher staining for LAMP-1 in tumor tissue compared to normal tissue (3986 ± 2635 vs. 1299 ± 1291, p < 0.001). Additionally, xenograft models showed a significantly higher contribution of cancer cells than the immune cells to cell surface LAMP1 expression. In vivo, PET imaging with 89Zr-DFO-anti-LAMP1 PET/CT revealed detectable tumor uptake as early as 24 h post-injection. The 89Zr-DFO-anti-LAMP1 tracer demonstrated significantly higher uptake than the control 89Zr-DFO-IgG in both models across all time points (MDA-MB-231 SUVmax at 168 h: 12.9 ± 5.7 vs. 4.4 ± 2.4, p = 0.003; Caco-2 SUVmax at 168 h: 8.53 ± 3.03 vs. 3.38 ± 1.25, p < 0.01). Conclusions: Imaging of cell surface LAMP-1 in breast and colon adenocarcinoma is feasible by immuno-PET. LAMP-1 imaging can be expanded to adenocarcinomas of other origins, such as prostate and pancreas.
MBRLCatalogueRelatedBooks
This website uses cookies to ensure you get the best experience on our website.